BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1379 related articles for article (PubMed ID: 31463827)

  • 1. DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.
    Liang Y; Zhang CD; Zhang C; Dai DQ
    Gastric Cancer; 2020 Mar; 23(2):212-227. PubMed ID: 31463827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.
    Li D; Tang X; Li M; Zheng Y
    J Cell Biochem; 2019 Aug; 120(8):12290-12299. PubMed ID: 30805988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
    Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
    Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Metastasis via the miR-155-5p/FGF7 Axis and Predicts Poor Prognosis in Gastric Cancer.
    Ma HW; Xi DY; Ma JZ; Guo M; Ma L; Ma DH; Li PW; Guo CA
    Dis Markers; 2020; 2020():8140989. PubMed ID: 32051698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.
    Wu Q; Ma J; Meng W; Hui P
    Cancer Biol Ther; 2020; 21(1):17-25. PubMed ID: 31591939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
    Jia P; Wei E; Liu H; Wu T; Wang H
    IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
    Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
    Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 11. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression.
    Guo W; Liang X; Liu L; Guo Y; Shen S; Liang J; Dong Z
    Gastric Cancer; 2019 Jul; 22(4):705-722. PubMed ID: 30656427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.
    Yang B; Jia L; Ren H; Jin C; Ren Q; Zhang H; Hu D; Zhang H; Hu L; Xie T
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1017. PubMed ID: 31782911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis.
    Ding Z; Lan H; Xu R; Zhou X; Pan Y
    Pathol Res Pract; 2018 Dec; 214(12):1993-1999. PubMed ID: 30279010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.
    Zhang LL; Zhang LF; Guo XH; Zhang DZ; Yang F; Fan YY
    DNA Cell Biol; 2018 Jan; 37(1):46-52. PubMed ID: 29215918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer.
    Teng F; Zhang JX; Chen Y; Shen XD; Su C; Guo YJ; Wang PH; Shi CC; Lei M; Cao YO; Liu SQ
    Mol Oncol; 2021 Apr; 15(4):1234-1255. PubMed ID: 33512745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.